---
figid: PMC11048329__cancers-16-01533-g002
figtitle: Schematic presentation of current evidence on Cx32 association with EMT
  and the HCC chemotherapeutic resistance with oxaliplatin or doxorubicin
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11048329
filename: cancers-16-01533-g002.jpg
figlink: /pmc/articles/PMC11048329/figure/F2
number: F2
caption: 'Schematic presentation of current evidence on Cx32 association with EMT
  and the HCC chemotherapeutic resistance with oxaliplatin or doxorubicin. Cx32 expression
  is negatively correlated with chemoresistance and EMT phenotype enhancement, while
  the downregulation of Cx32 upregulates Snail expression and promotes EMT via the
  activation of the Wnt/β-catenin signaling pathway. Thus, the Cx32/β-catenin/Snail
  pathway is as a potential therapeutic target in advanced HCC. (HCC: hepatocellular
  carcinoma; OR cells: oxaliplatin-resistant cells; DR cells: doxorubicin-resistant
  cells). Created with BioRender.com'
papertitle: 'Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular
  and Prognostic Implications'
reftext: Stavros P. Papadakos, et al. Cancers (Basel). 2024 Apr;16(8).
year: '2024'
doi: 10.3390/cancers16081533
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: connexins | gap junctions | hepatocellular carcinoma | expression | chemosensitivity
automl_pathway: 0.5980867
figid_alias: PMC11048329__F2
figtype: Figure
redirect_from: /figures/PMC11048329__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11048329__cancers-16-01533-g002.html
  '@type': Dataset
  description: 'Schematic presentation of current evidence on Cx32 association with
    EMT and the HCC chemotherapeutic resistance with oxaliplatin or doxorubicin. Cx32
    expression is negatively correlated with chemoresistance and EMT phenotype enhancement,
    while the downregulation of Cx32 upregulates Snail expression and promotes EMT
    via the activation of the Wnt/β-catenin signaling pathway. Thus, the Cx32/β-catenin/Snail
    pathway is as a potential therapeutic target in advanced HCC. (HCC: hepatocellular
    carcinoma; OR cells: oxaliplatin-resistant cells; DR cells: doxorubicin-resistant
    cells). Created with BioRender.com'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GJB1
  - HCC
  - HYCC1
  - ITK
  - SLC22A3
  - CDH1
  - FZR1
  - SNAI1
  - DKK1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
---
